Cargando…
Recombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: a review and meta-analysis of published data
BACKGROUND: The purpose of this study was to determine the role of recombinant activated factor VII (rFVIIa) in abdominal, vascular, and urological surgery. METHODS: We conducted meta-analyses of case series and placebo-controlled studies reporting on the treatment or prophylaxis of bleeding with rF...
Autores principales: | von Heymann, Christian, Jonas, Sven, Spies, Claudia, Wernecke, Klaus-Dieter, Ziemer, Sabine, Janssen, Detlev, Koscielny, Jürgen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374636/ https://www.ncbi.nlm.nih.gov/pubmed/18279513 http://dx.doi.org/10.1186/cc6788 |
Ejemplares similares
-
Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patients
por: Puetz, John
Publicado: (2010) -
The evidence for the use of recombinant factor VIIa in massive bleeding: revision of the transfusion policy framework
por: Lin, Y, et al.
Publicado: (2012) -
Recombinant factor VIIa for variceal bleeding in liver cirrhosis: still only a hope
por: Qi, Xingshun, et al.
Publicado: (2017) -
Factor VIIa for severe cardiac surgical bleeding
por: Diprose, P, et al.
Publicado: (2002) -
The evolution of factor VIIa in the treatment of bleeding in haemophilia with inhibitors
por: Meeks, Shannon L., et al.
Publicado: (2019)